| Author |
Title |
Year |
Publication |
Volume  |
Pages |
| McElhatton, P. R.; Bateman, D. N.; Evans, C.; Pughe, K. R.; Thomas, S. H. L. |
Congenital anomalies after prenatal ecstasy exposure |
1999 |
The Lancet |
354 |
1441-1442 |
| Meyer, Roger E. |
The disease called addiction : emerging evidence in a 200-year debate |
1996 |
The Lancet |
347 |
162-166 |
| Seivewright, Nicholas A.; Greenwood, Judy |
What is important in drug misuse treatment? |
1996 |
The Lancet |
347 |
373-376 |
| Mattick, Richard P.; Hall, Wayne |
Are detoxification programmes effective? |
1996 |
The Lancet |
347 |
97-100 |
| O'Brien, Charles P.; McLellan, Thomas |
Myths about the treatment of addiction |
1996 |
The Lancet |
347 |
237-240 |
| Nutt, David J. |
Addiction : brain mechanisms and their treatment implications |
1996 |
The Lancet |
347 |
31-36 |
| Edlin, Brian R.; Seal, Karen H.; Lorvick, Jennifer; Kral, Alex H.; Ciccarone, Daniel H.; Moore, Lisa D.; Lo, Bernard |
Is it justifiable to withhold treatment for hepatitis C from illicit-drug users? |
2001 |
The New England journal of medicine |
345 |
211-214 |
| Davis, Gary L.; Rodrigue, James R. |
Treatment of chronic hepatitis C in active drug users |
2001 |
The New England journal of medicine |
345 |
215-217 |
| McCarthy, Michael |
LA law and clean needles |
1994 |
The Lancet |
344 |
810 |
| Kuepper, Rebecca; van Os, Jim; Lieb, Roselind; Wittchen, Hans-Ulrich; Höfler, Michael; Henquet, Cécile |
Continued cannabis use and risk of incidence and persistence of psychotic symptoms : 10 year follow-up cohort study |
2011 |
British medical journal |
342 |
8 |
